Patricia P Kao, MD Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 186 Providence St, West Warwick, RI 02893 Phone: 401-615-2800 Fax: 401-615-2805 |
News Archive
An accurate, faster testing option to identify female carriers and other patients with genetic abnormalities that cause Fragile X Syndrome is now available to physicians in all fifty states with the recent approval in New York. Fragile X is the leading cause of inherited mental retardation and the most common known single gene cause of autism.
U.S. Renal Care, Inc., a privately-held leading provider of outpatient dialysis services, today announced that it has entered into definitive agreements with respect to the financing of its cash tender offer to acquire all of the outstanding shares of common stock of Dialysis Corporation of America as contemplated by the debt commitment letter with RBC Capital Markets, dated as of April 13, 2010.
BioCryst Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA), in response to a request from the U.S. Centers for Disease Control and Prevention (CDC), has issued an emergency use authorization (EUA) for the investigational anti-viral drug intravenous (i.v.) peramivir in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.
A recent study of the speech information rate of seven languages concludes that there is considerable variation in the speed at which languages are spoken, but much less variation in how efficiently languages communicate the same information.
› Verified 7 days ago